Top Suppliers:I want be here
Related CAS#:
1333316-01-0 1566917-56-3
1069098-66-3 1564853-39-9
1412416-37-5 1566983-28-5
945988-49-8 1565079-36-8
1434247-05-8 1565422-88-9

202138-50-9

202138-50-9 structure
202138-50-9 structure
  • Name: Tenofovir Disoproxil Fumarate
  • Chemical Name: tenofovir disoproxil fumarate
  • CAS Number: 202138-50-9
  • Molecular Formula: C23H34N5O14P
  • Molecular Weight: 635.515
  • Catalog: API Synthetic anti-infective drugs Antiviral drugs
  • Create Date: 2018-02-04 08:00:00
  • Modify Date: 2026-06-30 17:27:32
  • Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor used to treat HIV and chronic Hepatitis B.
Name tenofovir disoproxil fumarate
Synonyms Tenofovir Disoproxil fumateQ: What is Tenofovir Disoproxil fumate Q: What is the CAS Number of Tenofovir Disoproxil fumate Q: What is the storage condition of Tenofovir Disoproxil fumate Q: What e the applications of Tenofovir Disoproxil fumate
GS-4331-05
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-, 1,9-bis(1-Methylethyl) ester, 5-oxide, (2E)-2-butenedioate
Bis(neopentyloc)pmpa
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, bis(2,2-dimethylpropyl) ester, 5-oxide, (R)
(1R)-2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methyl-(isopropoxycbonyloxymethoxy)phosphoryl]oxymethyl isopropyl cbonate
GS-1278 Disoproxil Fumate
Tenofovir Disoproxil Fumate
Tenofovir disoproxil D12 fumate
202-9Tenofovir disoproxil fumate
Bis{[(isopropoxycarbonyl)oxy]methyl} ({[(2R)-1-(6-amino-9H-purin-9-yl)-2-propanyl]oxy}methyl)phosphonate (2E)-2-butenedioate (1:1)
Tenofovir dipivoxil FuMate(TDF)
Tenofovir diisoproxil fuMate
Tenofovir DF
9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine Fumarate
Tenofovir disoproxil Impurity 11
GS 4
Tenofovir Disproxil FuMate
9-((R)-2-((Bis(((isopropoxycbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine fumate
(R)-(((((1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(oxy))bis(methylene) diisopropyl bis(cbonate), fumic acid
enofovir disoproxil fuMate
Tenofovir (Disoproxil Fumarate)
Tenofovir Impurity 138 Fumate
Bis(((isopropoxycarbonyl)oxy)methyl) (((1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy)methyl)phosphonate (2E)-2-Butenedioate
TENOFOVIR DISOPROXIL FUMATE [DRUG SUBSTANCE(NON-STERILE)]
FuMic acid tenofovir ester
acide (2E)-but-2-ènedioïque - {[(1R)-2-(6-amino-9H-purin-9-yl)-1-méthyléthoxy]méthyl}phosphonate de bis({[(1-méthyléthoxy)carbonyl]oxy}méthyle) (1:1)
Bis{[(isopropoxycarbonyl)oxy]methyl} ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonate (2E)-but-2-enedioate (1:1)
Tenofovir disoproxil fumate 9-((R)-2-((Bis(((isopropoxycbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine fumate
Tenofovir disoproxil fumate RS
Tenofovir Disoroxil Fumate
Tenofovir disoproxil fumate - Bio-X
1,3-Benzodioxole-5-cboxaldehyde,12-methoxy
Tenofovir disoproxil fumate //BP
bis{[(isopropoxycbonyl)oxy]methyl} ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonate (2E)-but-2-enedioate (1:1)
5-[[(1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]-2,4,6,8-tetraoxa-5-phosphanonanedioic Acid 1,9-Bis(1-methylethyl) Ester 5-Oxide (2E)-2-Butenedioate
Tenofovir Disoproxil Fumate, 10 mM in DMSO
Tenofovir disoproxil fumarate
Tenofovir Disoproxil Dumate
Viread
bis({[(1-methylethoxy)carbonyl]oxy}methyl) {[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl}phosphonate (2E)-but-2-enedioate
Tenofovir disoproxil fumate, >=
2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, 1,9-bis(1-methylethyl) ester, 5-oxide, (2E)-2-butenedioate (1:1)
Tenofovir Disoproxil Fumate (USFDA)
Tenofovir Disoproxil Fumate (TDF)
Tenofovir Disoproxil Fumate CRS
GS4331-05
Viread (TN)
Aids-031697
Tenofovir diisoproxil fuMarate
Carbonic acid, [[[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl][[[(1-methylethoxy)carbonyl]oxy]methoxy]phosphinyl]oxy]methyl 1-methylethyl ester, (2E)-2-butenedioate (1:1)
bis({[(propan-2-yloxy)carbonyl]oxy}methyl) ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonate (2E)-but-2-enedioate (1:1)
Tenofovir Disoproxil Fumate (Tenofovir DF)
GS-433105
Tenofovir dipivoxil Fumate
(R)-(((((1-(6-Amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(oxy))bis(methylene) di
Disoproxil fumate
Tenofovir Disoproxil FuMate I
TENOFOVIR DISOPROXIL FUMATE (NON-STERILE DRUG SUBSTANCE)
Aids031697
(((((1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)Methyl)phosphoryl)bis(oxy))bis(Methylene) diisopropyl dicbonate fuMate
Tenofovir Impurity 115 Fumate
TENOFOVIR DISOPROXIC
Description Tenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor used to treat HIV and chronic Hepatitis B.
Related Catalog
In Vitro Tenofovir shows cytotoxic effects on cell viability in HK-2 cells, with IC50 values of 9.21 and 2.77 μM at 48 and 72 h in MTT assay, respectively. Tenofovir diminishes ATP levels in HK-2 cells. Tenofovir (3.0 to 28.8 μM) increases oxidative stress and protein carbonylation in HK-2 cells. Furthermore, Tenofovir induces apoptosis in HK-2 cells, and that apoptosis is induced via mitochondrial damage[1]. Tenofovir and M48U1 formulated in 0.25% HEC each inhibits the replication of both R5-tropic HIV-1BaL and X4-tropic HIV-1IIIb in activated PBMCs, and inhibits several laboratory strains and patient-derived HIV-1 isolates. The combined formulation of M48U1 and tenofovir in 0.25% HEC exhibits synergistic antiretroviral activity against infection with R5-tropic HIV-1BaL, and is not toxic to PBMCs[2].
In Vivo Tenofovir Disoproxil Fumarate (20, 50, 140, or 300 mg/kg) administered to BLT mice, shows dose dependent activity during vaginal HIV challenge in BLT humanized mice. Tenofovir Disoproxil Fumarate (50, 140, 300 mg/kg) significantly reduces HIV transmission in BLT mice[3]. Tenofovir Disoproxil Fumarate (0.5, 1.5, or 5.0 mg/kg/day, p.o.) induces a dose-dependent decline in serum viremia in woodchucks chronically infected with WHV. Tenofovir Disoproxil Fumarate administration is safe and effective in the woodchuck model of chronic HBV infection[4].
Cell Assay Cells are plated into 48-well tissue culture plates (39,000 cells/mL) and allowed to grow for 48 h followed by treatment with vehicle or Tenofovir. Following the treatment period, cell viability is assessed using the MTT assay. The MTT assay relies on the conversion of tetrazolium dye 3-(4,5-dimethlthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to formazan by NAD(P)H-dependent oxidoreductases.
Animal Admin Twenty adult chronic WHV carrier woodchucks are stratified equally by age, sex, body weight, and serum GGT activity into five treatment groups consisting of four animals each: (i) Tenofovir Disoproxil Fumarate at 15.0 mg/kg once per day, (ii) Tenofovir Disoproxil Fumarate at 5.0 mg/kg/day, (iii) Tenofovir Disoproxil Fumarate at 1.5 mg/kg/day, (iv) Tenofovir Disoproxil Fumarate at 0.5 mg/kg/day, and (v) a placebo control. The woodchucks are treated daily for 4 weeks and observed for an additional 12 weeks following cessation of drug treatment.
References

[1]. Murphy RA, et al. Establishment of HK-2 Cells as a Relevant Model to Study Tenofovir-Induced Cytotoxicity. Int J Mol Sci. 2017 Mar 1;18(3)

[2]. Musumeci G, et al. M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures. Sci Rep. 2017 Feb 1;7:41018

[3]. Wahl A, et al. Predicting HIV Pre-exposure Prophylaxis Efficacy for Women using a Preclinical Pharmacokinetic-Pharmacodynamic In Vivo Model. Sci Rep. 2017 Feb 1;7:41098

[4]. Menne S, Cote PJ, Korba BE, Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection. Antimicrob Agents Chemother. 2005 Jul;49(7):2720-8.

[5]. Xu P, et al. Combined Medication of Antiretroviral Drugs Tenofovir Disoproxil Fumarate, Emtricitabine, and Raltegravir Reduces Neural Progenitor Cell Proliferation In Vivo and In Vitro. J Neuroimmune Pharmacol. 2017 Dec;12(4):682-692.
Density 1.45 g/cm3
Boiling Point 642.7ºC at 760 mmHg
Melting Point 219ºC
Molecular Formula C23H34N5O14P
Molecular Weight 635.515
Flash Point 342.5ºC
Exact Mass 635.183960
PSA 269.85000
LogP 3.32860
Vapour Pressure 2.06E-16mmHg at 25°C
Storage condition Refrigerator
Symbol GHS05
GHS05
Signal Word Danger
Hazard Statements H318
Precautionary Statements P280-P305 + P351 + P338 + P310
Hazard Codes Xi
Risk Phrases R36/37/38
Safety Phrases 26-36
RIDADR NONH for all modes of transport
HS Code 2933990090
HS Code 2933990090
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Chemsrc provides CAS#:202138-50-9 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 202138-50-9 | Chemsrc address: https://m.chemsrc.com/en/baike/1152709.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2026 ChemSrc All Rights Reserved